Clinic fit quiz
Open full calculatorYour priorities (0 of 10 answered)
Visit fees, memberships and labs, not the drug.
Pick every one that applies. Each one raises the value of closer, synchronous follow-up.
Compounded GLP-1s are not FDA approved and are not interchangeable with brand products.
Dietitian visits, body composition, on-site labs, exercise guidance.
How each care model matches what you said
Answer at least five questions to see a ranking. The quiz scores four care models, not clinics. It will never name a provider.
The quiz above asks ten questions about what you want from GLP-1 care and returns a ranking of four care models, with the reason each one earned or lost points and the trade-off behind every answer you gave. It is an aid to thinking, built to be argued with.
What it measures
Priorities, not suitability. Speed, whether you want to be examined, whether visits must go through insurance, how you think about the cost of care, conditions that need closer monitoring, whether you have a primary clinician, how you prefer to communicate, which medication route you expect, how far you will travel, and what else you want from the program. Each answer adds between 0 and 3 points to each of the four models. The weights are printed in the source and the formula panel shows the arithmetic.
How the weights were set
Editorially, from three kinds of source. The Wegovy and Zepbound labels set the monitoring weights: hypoglycemia risk with insulin or a sulfonylurea, kidney injury after dehydration, pancreatitis and gallbladder warnings, the pregnancy instructions. The FSMB 2022 report sets the weight against questionnaire-only care. The AACE/ACE guideline and what the four models typically offer set the rest. Where a weight is a judgement about what a model usually does, the trade-off text says so and tells you what to confirm.
What a result means
A model at 85 percent is one whose usual strengths line up with what you said you want. It is not a statement about any clinic. Two clinics of the same model can differ more than two models do, which is why every result ends in trade-offs to check rather than a verdict. When the top two are within five points the quiz says so; the choice between them will come from the specific clinics, not the model.
The monitoring notes are the part to take most seriously. If you ticked a condition, the notes say what any clinic, of any model, would need to do about it. A remote program that does those things is fine. One that does not is not, however well it scores on speed.
What it does not do
It does not decide whether you should take a GLP-1; only a prescriber with your history can. It does not name, rank or recommend clinics; formblendsreviews.com evaluates named programs on a published rubric. It does not know your state's rules; formblendsdirectory.com does. It stores nothing; your answers stay in your browser and disappear when you close the page.
Taking the result to a clinic
- Read the page for your top one or two models: in-person, primary care, telehealth-only, hybrid.
- Print or copy the result. The trade-offs list is, in effect, your personal set of things to confirm.
- Add the first-call questions that the clinic's website leaves unanswered.
- Check the licence and the pharmacy yourself: what prescriber means and evaluating a clinic's pharmacy partner.
Questions people ask
Does the quiz recommend a clinic?
No. It ranks four care models against the priorities you state and explains the trade-off behind each answer. It contains no provider data and never names one. For scored evaluations of named programs, see formblendsreviews.com.
Why did ticking a health condition change the ranking so much?
Because conditions such as diabetes on insulin, kidney disease or a history of pancreatitis carry label warnings that need closer, synchronous follow-up and repeat labs. The quiz weights those answers toward models that examine you and manage your other medication. It is not saying you cannot use a remote program; it is saying the program would need to do those things.
Sources
- FSMB. The Appropriate Use of Telemedicine Technologies in the Practice of Medicine: Report of the FSMB Workgroup on Telemedicine, April 2022 Accessed September 4, 2026.
- Wegovy (semaglutide) prescribing information, DailyMed set id ee06186f-2aa3-4990-a760-757579d8f77b Accessed September 4, 2026.
- Zepbound (tirzepatide) prescribing information, DailyMed set id 487cd7e7-434c-4925-99fa-aa80b1cc776b Accessed September 4, 2026.
- Garvey WT et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 2016. PubMed 27219496 Accessed September 4, 2026.
Canonical URL: https://formblendsclinics.com/reference/how-to-use-the-fit-quiz. Written by the FormBlends editorial team. This page is educational and is not medical advice; see the medical disclaimer.